Authors:
PYRHONEN S
VALAVAARA R
MODIG H
PAWLICKI M
PIENKOWSKI T
GUNDERSEN S
BAUER J
WESTMAN G
LUNDGREN S
BIANCO G
MELLA O
NILSSON I
HIETANEN T
HINDY I
VUORINEN J
HAJBA A
Citation: S. Pyrhonen et al., COMPARISON OF TOREMIFENE AND TAMOXIFEN IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - A RANDOMIZED DOUBLE-BLIND, THE NORDIC PHASE-III STUDY, British Journal of Cancer, 76(2), 1997, pp. 270-277
Authors:
SUHONENPOLVI H
SALMI TT
KORHONEN T
NORVASUOHEILA MK
RUOTSALAINEN U
RIIKONEN R
BERGMAN J
HAAPARANTA M
NUUTILA P
VALAVAARA R
SONNINEN P
WEGELIUS U
Citation: H. Suhonenpolvi et al., CEREBRAL GLUCOSE-UTILIZATION MEASURED WITH POSITRON EMISSION TOMOGRAPHY (PET) AS AN INDEX FOR NEUROLOGICAL FUNCTIONING IN LONG-TERM SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL), International journal of pediatric hematology/oncology, 2(1), 1995, pp. 63-71
Authors:
MANTYLA E
GYLLING H
KANGAS L
PYRHONEN S
MAENPAA H
VALAVAARA R
MIETTINEN T
Citation: E. Mantyla et al., TAMOXIFEN AND TOREMIFENE - THE BENEFICIAL HYPOLIPEMIC EFFECT IN WOMENIS MEDIATED BY CHOLESTEROL-BIOSYNTHESIS INHIBITION, European journal of cancer, 31A, 1995, pp. 60-60
Authors:
MAJURIN ML
VALAVAARA R
VARPULA M
KURKI T
KULMALA J
Citation: Ml. Majurin et al., LOW-DOSE AND CONVENTIONAL-DOSE HIGH-RESOLUTION CT OF PULMONARY CHANGES IN BREAST-CANCER PATIENTS TREATED BY TANGENTIAL FIELD RADIOTHERAPY, European journal of radiology, 20(2), 1995, pp. 114-119
Authors:
PYRHONEN S
VALAVAARA R
VUORINEN J
HAJBA A
Citation: S. Pyrhonen et al., HIGH-DOSE TOREMIFENE IN ADVANCED BREAST-CANCER RESISTANT TO OR RELAPSED DURING TAMOXIFEN TREATMENT, Breast cancer research and treatment, 29(3), 1994, pp. 223-228